Get the Stockscreener App
22.54
0.13%
0.03
After Hours:
22.54
Privia Health Group Inc Stock (PRVA) Latest News
Park Avenue Securities LLC Increases Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27 - The Manila Times
Privia Health to Report Fourth Quarter 2024 Results on Thursday, February 27 - GlobeNewswire Inc.
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Purchased by Riverbridge Partners LLC - MarketBeat
Privia Health Group (NASDAQ:PRVA) Sets New 1-Year HighHere's What Happened - MarketBeat
Privia Health stock hits 52-week high at $23.38 amid market optimism - Investing.com
An Intrinsic Calculation For Privia Health Group, Inc. (NASDAQ:PRVA) Suggests It's 49% Undervalued - Yahoo Finance
JPMorgan Chase & Co. Boosts Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
JPMorgan Chase & Co. Has $3.43 Million Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Learn to Evaluate (PRVA) using the Charts - Stock Traders Daily
Critical Analysis: Vsee Health (NASDAQ:VSEE) & Privia Health Group (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by Harbor Capital Advisors Inc. - Defense World
Insiders At Privia Health Group Sold US$898k In Stock, Alluding To Potential Weakness - Simply Wall St
Privia Health Group (NASDAQ:PRVA) Research Coverage Started at Needham & Company LLC - Defense World
Needham Initiates Coverage of Privia Health Group (PRVA) with Buy Recommendation - MSN
Privia Health stock backed by Needham for strong 2025 outlook in VBC space - Investing.com Australia
Privia Health Group (NASDAQ:PRVA) Earns Buy Rating from Analysts at Needham & Company LLC - MarketBeat
Nordea Investment Management AB Purchases 86,910 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Receives $24.88 Consensus Target Price from Analysts - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Given Average Rating of “Buy” by Brokerages - Defense World
Privia Health Group (NASDAQ:PRVA) Receives “Overweight” Rating from Stephens - Defense World
A Glimpse Into The Expert Outlook On Privia Health Gr Through 6 Analysts - Benzinga
Privia Health Group (NASDAQ:PRVA) Given Overweight Rating at Stephens - MarketBeat
Privia Health Group, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
When (PRVA) Moves Investors should Listen - Stock Traders Daily
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Sold by MML Investors Services LLC - Defense World
Geode Capital Management LLC Grows Position in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
HighTower Advisors LLC Has $338,000 Stake in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Position Decreased by Principal Financial Group Inc. - MarketBeat
Barclays PLC Acquires 158,188 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
DH vs. PRVA: Which Stock Is the Better Value Option? - Yahoo Finance
Franklin Resources Inc. Grows Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Stifel Financial Corp Has $2.41 Million Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
State Street Corp Lowers Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Privia Health Group (NASDAQ:PRVA) Shares Down 5.2%Should You Sell? - MarketBeat
3 US Stocks That May Be Trading Below Their Estimated Value - Simply Wall St
Privia Health Group (NASDAQ:PRVA) Now Covered by Macquarie - Defense World
Macquarie sets shares price target on Privia Health, cites growth By Investing.com - Investing.com Australia
Macquarie Initiates Coverage on Privia Health Group (NASDAQ:PRVA) - MarketBeat
Macquarie sets shares price target on Privia Health, cites growth - Investing.com
Privia Health's SWOT analysis: navigating growth in a complex healthcare stock landscape - Investing.com Australia
Privia Health Group, Inc. (NASDAQ:PRVA) Receives $24.79 Consensus Target Price from Brokerages - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Rating of “Buy” from Brokerages - Defense World
0.79%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):